Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine

Abstract Anxiety-related disorders, including fearfulness are common and leading welfare problems among the worldwide dog population. The etiology of anxieties is complex and affected by genetic and environmental factors. Thus, there is a need for more comprehensive approaches, such as metabolomics,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jenni Puurunen, Katriina Tiira, Katariina Vapalahti, Marko Lehtonen, Kati Hanhineva, Hannes Lohi
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b29bc7bd7c524963abb3fcdeaa0b68c6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b29bc7bd7c524963abb3fcdeaa0b68c6
record_format dspace
spelling oai:doaj.org-article:b29bc7bd7c524963abb3fcdeaa0b68c62021-12-02T15:08:13ZFearful dogs have increased plasma glutamine and γ-glutamyl glutamine10.1038/s41598-018-34321-x2045-2322https://doaj.org/article/b29bc7bd7c524963abb3fcdeaa0b68c62018-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-34321-xhttps://doaj.org/toc/2045-2322Abstract Anxiety-related disorders, including fearfulness are common and leading welfare problems among the worldwide dog population. The etiology of anxieties is complex and affected by genetic and environmental factors. Thus, there is a need for more comprehensive approaches, such as metabolomics, to understand the causes of anxiety and to identify anxiety-related biomarkers for more efficient diagnostic and treatment options. To study metabolic alterations related to canine fearfulness, a non-targeted plasma metabolite profiling was performed in a cohort of 20 fearful and 21 non-fearful dogs. The results showed that nine metabolic features were significantly associated with fearfulness. The most prominent change included increased plasma glutamine and γ-glutamyl glutamine (γ-Glu Gln) in fearful dogs across breeds. Alterations in glutamine metabolism have previously been associated with several psychiatric disorders, indicating the relevance of this finding also in dogs. In addition, we describe a novel breed-specific association between renal biomarker symmetric dimethylarginine (SDMA) and canine fearfulness. These observed metabolic alterations may result from high levels of prolonged psychological stress in fearful dogs.Jenni PuurunenKatriina TiiraKatariina VapalahtiMarko LehtonenKati HanhinevaHannes LohiNature PortfolioarticleFear DogsIncreased Plasma GlutamineSymmetric Dimethylarginine (SDMA)Prolonged Psychological StressStandard Logistic Regression AnalysisMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-12 (2018)
institution DOAJ
collection DOAJ
language EN
topic Fear Dogs
Increased Plasma Glutamine
Symmetric Dimethylarginine (SDMA)
Prolonged Psychological Stress
Standard Logistic Regression Analysis
Medicine
R
Science
Q
spellingShingle Fear Dogs
Increased Plasma Glutamine
Symmetric Dimethylarginine (SDMA)
Prolonged Psychological Stress
Standard Logistic Regression Analysis
Medicine
R
Science
Q
Jenni Puurunen
Katriina Tiira
Katariina Vapalahti
Marko Lehtonen
Kati Hanhineva
Hannes Lohi
Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
description Abstract Anxiety-related disorders, including fearfulness are common and leading welfare problems among the worldwide dog population. The etiology of anxieties is complex and affected by genetic and environmental factors. Thus, there is a need for more comprehensive approaches, such as metabolomics, to understand the causes of anxiety and to identify anxiety-related biomarkers for more efficient diagnostic and treatment options. To study metabolic alterations related to canine fearfulness, a non-targeted plasma metabolite profiling was performed in a cohort of 20 fearful and 21 non-fearful dogs. The results showed that nine metabolic features were significantly associated with fearfulness. The most prominent change included increased plasma glutamine and γ-glutamyl glutamine (γ-Glu Gln) in fearful dogs across breeds. Alterations in glutamine metabolism have previously been associated with several psychiatric disorders, indicating the relevance of this finding also in dogs. In addition, we describe a novel breed-specific association between renal biomarker symmetric dimethylarginine (SDMA) and canine fearfulness. These observed metabolic alterations may result from high levels of prolonged psychological stress in fearful dogs.
format article
author Jenni Puurunen
Katriina Tiira
Katariina Vapalahti
Marko Lehtonen
Kati Hanhineva
Hannes Lohi
author_facet Jenni Puurunen
Katriina Tiira
Katariina Vapalahti
Marko Lehtonen
Kati Hanhineva
Hannes Lohi
author_sort Jenni Puurunen
title Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
title_short Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
title_full Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
title_fullStr Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
title_full_unstemmed Fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
title_sort fearful dogs have increased plasma glutamine and γ-glutamyl glutamine
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/b29bc7bd7c524963abb3fcdeaa0b68c6
work_keys_str_mv AT jennipuurunen fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
AT katriinatiira fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
AT katariinavapalahti fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
AT markolehtonen fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
AT katihanhineva fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
AT hanneslohi fearfuldogshaveincreasedplasmaglutamineandgglutamylglutamine
_version_ 1718388273746804736